HIMS · Hims & Hers Health, Inc. · Executive Compensation
$29.38
+0.17 (+0.58%)
At close · Oct 21
View the 10-K filed Feb 23, 2026
Return incl. dividend (before tax)
Customer concentration
— top customer 10% of receivables
One customer — 10% of receivables (December 31, 2025)
“As of December 31, 2025, one customer or partner individually represented more than 10% of accounts receivable.”
4 customers — 10% of receivables (December 31, 2024)
“As of December 31, 2024, four customers or partners individually represented more than 10% of accounts receivable.”
Market Cap
$6.82B
Shares
233.31M
Volume · Oct 20
10.55M
Avg daily vol (3M)
12.08M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Mr. Elshenawy | Chief Technology Officer | $60,869,746 |
| Mr. Dudum | Chief Executive Officer and Chairman | $22,958,907 |
| Mr. Kabbani | Former Chief Operating Officer | $14,862,305 |
| Mr. Okupe | Chief Financial Officer | $8,398,808 |
| Ms. Baird | Former Chief Operating Officer | $8,392,871 |
| Mr. Chi | Chief Operating Officer (previously Chief Commercial Officer) | $7,727,713 |
| Ms. Boughton | Chief Legal Officer | $4,796,709 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mr. Dudum | Chief Executive Officer and Chairman | $24,609,077 |
| Ms. Baird | Chief Operating Officer | $9,083,971 |
| Mr. Okupe | Chief Financial Officer | $8,196,173 |
| Mr. Chi | Chief Commercial Officer | $7,008,181 |
| Ms. Boughton | Chief Legal Officer | $4,673,336 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mr. Dudum | Chief Executive Officer and Chairman | $14,401,411 |
| Mr. Okupe | Chief Financial Officer | $7,432,394 |
| Ms. Baird | Chief Operating Officer | $6,765,760 |
| Mr. Chi | Chief Commercial Officer | $6,709,160 |
| Ms. Boughton | Chief Legal Officer | $5,212,071 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mr. Dudum | Chief Executive Officer and Chairman | $10,816,547 |
| Mr. Okupe | Chief Financial Officer | $7,422,692 |
| Ms. Baird | Chief Operating Officer | $6,359,003 |
| Ms. Boughton | Chief Legal Officer | $3,956,763 |
| Mr. Chi | Chief Commercial Officer | $3,956,763 |
| Ms. Becklund | Former Interim Principal Financial Officer | $961,116 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mr. Dudum | Chief Executive Officer and Chairman | $15,230,255 |
| Mr. Lee Former | Chief Financial Officer | $5,898,453 |
| Ms. Baird | Chief Operating Officer | $4,778,151 |
| Ms. Boughton | Chief Legal Officer | $2,722,484 |
| Dr. Carroll | Former Chief Medical Officer | $1,771,106 |
| Ms. Becklund | Former Interim Principal Financial Officer | $1,482,124 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Andrew Dudum | Chief Executive Officer and Director | $26,575,833 |
| Mr. Dudum | Chief Executive Officer and Chairman | $26,575,832 |
| Ms. Baird | Chief Operating Officer | $4,346,963 |
| Melissa Baird | Chief Operating Officer | $4,346,532 |
| Mr. Lee Former | Chief Financial Officer | $3,368,418 |
| Spencer Lee | Chief Financial Officer | $3,281,119 |
| Ms. Boughton | Chief Legal Officer | $2,273,092 |
| Dr. Carroll | Former Chief Medical Officer | $1,803,456 |
| Ms. Becklund | Former Interim Principal Financial Officer | $1,246,767 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Mr. Lee Former | Chief Financial Officer | $2,176,270 |
| Ms. Boughton | Chief Legal Officer | $543,118 |
| Dr. Carroll | Former Chief Medical Officer | $520,446 |
| Ms. Baird | Chief Operating Officer | $475,436 |
| Andrew Dudum | Chief Executive Officer and Director | $253,750 |
| Mr. Dudum | Chief Executive Officer and Chairman | $253,750 |
| Ms. Becklund | Former Interim Principal Financial Officer | $195,486 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Irene Becklund | principal accounting officer | Resigned | 2026-10-07 |
| Jonathan M. Franklin | principal accounting officer | Appointed | 2026-10-07 |
| Jonathan M. Franklin | chief accounting officer | Appointed | 2026-10-07 |
| Irene Becklund | Chief Accounting Officer and Principal Accounting Officer | Resigned | 2026-07-17 |
| Mike Chi | Chief Operating Officer | Appointed | 2025-10-02 |
| Deb Autor | director | Appointed | 2024-11-21 |
| Kåre Schultz | director | Appointed | 2024-07-22 |
| Anja Manuel | director | Appointed | 2024-04-26 |
| Christopher Payne | director | Appointed | 2024-04-03 |
| Christiane Pendarvis | director | Appointed | 2023-02-23 |
Leadership
- Andrew Dudum CEO, Board Member
- Mr. Dudum CEO
- Irene A. Becklund CFO
- Mr. Lee Former CFO
- Mr. Okupe CFO
- Melissa Baird COO
- Mike Chi COO
- Mr. Chi COO
- Mr. Kabbani COO
- Ms. Baird COO
- Mr. Elshenawy CTO
- Jonathan M. Franklin Chief Accounting Officer
- Andrea Perez Board Member
- Anja Manuel Board Member
- Christopher Payne Board Member
- David Wells Board Member
- Deb Autor Board Member
- Delos Cosgrove Board Member
- Dr. Toby Cosgrove Board Member
- Kofi Amoo-Gottfried Board Member
- Kåre Schultz Board Member
- Lynne Chou O'Keefe Board Member
- Toby Cosgrove Board Member
Key facts
CIK
1773751
CUSIP
433000106
13F (30d)
65 filings
58 filers
Visit website
Investor relations